News & Blog

Tag Archives: FDA

Creating a Better Path for Brain Tumor Drug Approval

At the end of summer we told you all about a new initiative of the National Brain Tumor Society called the Clinical Trial Endpoints Initiative, which aims to jumpstart brain tumor treatment development. At the time we were just getting back from an extremely fruitful meeting with the U.S. Food & Drug Administration (FDA), which […]

Jumpstarting Brain Tumor Drug Development

National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.

Share